| Balm International Health Care Centers, Llc | |
|
507 S Main St, Linden, AL 36748-2025 | |
| (334) 578-2357 | |
| (334) 295-5596 |
| Full Name | Balm International Health Care Centers, Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 507 S Main St, Linden, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417188525 | NPI | - | NPPES |
| DQ1809 | Other | AL | RAILROAD MEDICARE |
| 113457 | Medicaid | AL | |
| 1417188525 | Other | AL | TRICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 291 (Alabama) | Primary |
| Provider Name | Keturah Craig |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1386814457 PECOS PAC ID: 7214016252 Enrollment ID: I20080502000147 |
News Archive
Measuring calcium deposits in the heart's arteries can help predict overall death risk in American adults, even when they are elderly, according to a new study published in the July issue of Journal of the American College of Cardiology.
The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections.
In his latest New York Times column, Nicholas Kristof writes about the "unavailability of birth control in many poor countries," noting some experiences from a recent trip to Africa.
After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Balm International Health Care Centers, Llc Po Box 661495, Birmingham, AL 35266-1495 Ph: (205) 979-5882 | Balm International Health Care Centers, Llc 507 S Main St, Linden, AL 36748-2025 Ph: (334) 578-2357 |
News Archive
Measuring calcium deposits in the heart's arteries can help predict overall death risk in American adults, even when they are elderly, according to a new study published in the July issue of Journal of the American College of Cardiology.
The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections.
In his latest New York Times column, Nicholas Kristof writes about the "unavailability of birth control in many poor countries," noting some experiences from a recent trip to Africa.
After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 1 days ago
Keturah Craig, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 507 S Main St, Linden, AL 36748 Phone: 334-578-2357 Fax: 334-295-5596 |